RxDoctor Payments Data

Paul Kraemer, MD

Orthopaedic Surgery of the Spine · Carmel, INNPI 1770535411

Payments from drug & device makers

What this record shows

The money is spread across several categories — royalties or licence payments (29.4%), speaking fees and consulting fees — rather than concentrated in one kind of arrangement. 26 manufacturers reported payments, led by Medtronic at 40.3% of the total. Reporting peaked in 2019 at $78,266 and has fallen 80.7% since, to $15,093 in 2025.

$276,144in general payments, 2019–2025

Across 509 payments — averaging $542.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$111K
  • Stryker$81K
  • Globus Medical$49K
  • Medical Device Business Services, Inc.$15K
  • Intrinsic Therapeutics$7K
  • Zimmer Biomet$6K
  • plus $6K from 20 others
$21,220in research payments, 2019–2025

Across 12 payments — averaging $1768.29 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Intrinsic Therapeutics$16K
  • Stryker$5K

What the payments were for

  • Royalty or licence$81,24329%
  • Consulting fees$78,12828%
  • Speaking & faculty fees$78,33828%
  • Travel & lodging$23,8639%
  • Food & beverage$8,3833%
  • Education$6,1902%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$276,144 in reported general payments places this provider in the 80th percentile of 48 orthopaedic surgery of the spine providers in Indiana.

See all orthopaedic surgery of the spine providers in Indiana

Medicare billing

Part B allowed, 2024
$350,104
Medicare patients
291
Services billed
3,474

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen46$424
Methylprednisolone45$314
Gabapentin20$135
Oxycodone Hcl11$129
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen16$127
Cyclobenzaprine Hcl16$48
Tramadol Hcl13$36

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery of the spine in Carmel

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →